PCA Rx & Value Plus Medication are working collectively to remodel drug value transparency
What you must know:
– PCA Rx and Value Plus Medication are becoming a member of forces to deal with the long-standing downside of opaque and inflated drug costs within the U.S. healthcare system.
– This groundbreaking partnership paves the best way for better transparency, accessibility and affordability for employers and people throughout the nation.
Prioritize drug value transparency
By prioritizing transparency, this partnership empowers employers and members to make knowledgeable decisions and promotes a extra engaged healthcare neighborhood. It represents a serious step ahead in remodeling the trade's strategy to drug pricing and paves the best way for a extra accessible and inexpensive healthcare system for all.
PCA Rx, identified for its clear PBM mannequin, and Value Plus Medication, the brainchild of Mark Cuban targeted on cost-plus pricing, share a mission to offer sufferers and employers with clear details about medicine prices. This partnership combines their experience to ship an unprecedented stage of readability in drug pricing, addressing a serious ache level in healthcare.
This collaboration actively seeks options to prescription affordability challenges. Kelly Cromer, PharmD, VP of Operations & Scientific at PCA Rx, emphasizes, “PCA Rx and Value Plus Medication are dedicated to reducing drug costs and growing transparency, permitting people and employers to make knowledgeable healthcare choices.”